The company was founded in 2003 and is located in Nanjing Economic and Technological Development Zone. It is a high-tech enterprise integrating pharmaceutical R&D, production and marketing. The company has a GMP standard workshop for freeze-dried powder injections, small-volume injections, cephalosporin injections, solid preparations and APIs. Mainly engaged in R&D, production and sales of chemical preparations, APIs and intermediates. The main products are injectable landilol hydrochloride, rivaroxaban tablets, tigecycline for injections, torasemide for injections, and cefazidone sodium for injections. Corporate honors: “National Torch Program Key High-tech Enterprise”, “High-growth Small and Medium Enterprise in Jiangsu Province”, “Advanced Industry-University-Research Enterprise”, “Advanced Technological Innovation Enterprise”, “Labor and Social Security Integrity Enterprise”, etc. The company was awarded honorary titles such as “Enterprise with Outstanding Contribution to High Quality Development”, “Outstanding Enterprise with Leading Scientific and Technological Innovation”, “Outstanding Contributing Enterprise to High Quality Development”, and “Nanjing Collective Negotiation Three-Star Enterprise Award” in the Nanjing Economic and Technological Development Zone in 2022.
No Data